内行
发表于 2025-3-26 21:33:42
http://reply.papertrans.cn/47/4611/461072/461072_31.png
灯丝
发表于 2025-3-27 02:08:52
urce for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop 978-4-431-56281-8978-4-431-55582-7
怕失去钱
发表于 2025-3-27 07:50:17
Hiroyuki Nakamura,Kazutetsu AoshibaIntroducing new developments such as serum makers that are highly specific to IPF, the establishment of systematic diagnosis imaging and antifibrotic agent.Each chapter addresses key issues under disc
浪费物质
发表于 2025-3-27 12:26:28
http://reply.papertrans.cn/47/4611/461072/461072_34.png
Absenteeism
发表于 2025-3-27 16:13:03
http://reply.papertrans.cn/47/4611/461072/461072_35.png
EVEN
发表于 2025-3-27 18:48:03
http://reply.papertrans.cn/47/4611/461072/461072_36.png
发起
发表于 2025-3-27 23:53:40
Epidemiology and Risk Factors of IPFfibrosis (IPF) is worse than any form of other IIPs, because there are few effective treatments clinically approved. Although many risk factors are recognized, the etiologies of fibrotic lung diseases are not clear. Genetic background and environmental factors are thought to be involved in the etiol
Mets552
发表于 2025-3-28 02:45:33
http://reply.papertrans.cn/47/4611/461072/461072_38.png
NAV
发表于 2025-3-28 07:02:35
http://reply.papertrans.cn/47/4611/461072/461072_39.png
项目
发表于 2025-3-28 13:34:27
http://reply.papertrans.cn/47/4611/461072/461072_40.png